Fluorine in PDB 6f2u: Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
Enzymatic activity of Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
All present enzymatic activity of Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid:
1.1.1.112;
1.1.1.188;
1.1.1.239;
1.1.1.357;
1.1.1.64;
Protein crystallography data
The structure of Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid, PDB code: 6f2u
was solved by
P.Goyal,
W.Y.Wahlgren,
R.Friemann,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
39.86 /
1.88
|
Space group
|
P 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
41.046,
53.936,
76.714,
102.12,
85.42,
103.69
|
R / Rfree (%)
|
19.7 /
24.8
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
(pdb code 6f2u). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the
Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid, PDB code: 6f2u:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
Fluorine binding site 1 out
of 6 in 6f2u
Go back to
Fluorine Binding Sites List in 6f2u
Fluorine binding site 1 out
of 6 in the Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F402
b:42.0
occ:1.00
|
F26
|
A:CJ2402
|
0.0
|
42.0
|
1.0
|
C25
|
A:CJ2402
|
1.4
|
38.6
|
1.0
|
F27
|
A:CJ2402
|
2.2
|
40.2
|
1.0
|
F28
|
A:CJ2402
|
2.2
|
39.4
|
1.0
|
C23
|
A:CJ2402
|
2.4
|
36.7
|
1.0
|
C24
|
A:CJ2402
|
3.1
|
34.1
|
1.0
|
CG
|
A:ASN167
|
3.3
|
34.0
|
1.0
|
CB
|
A:ASN167
|
3.3
|
31.4
|
1.0
|
C21
|
A:CJ2402
|
3.3
|
35.8
|
1.0
|
ND2
|
A:ASN167
|
3.6
|
31.4
|
1.0
|
OD1
|
A:ASN167
|
3.7
|
32.6
|
1.0
|
OG
|
A:SER118
|
3.9
|
35.8
|
1.0
|
CG
|
A:PRO318
|
3.9
|
44.2
|
1.0
|
CB
|
A:SER118
|
4.2
|
33.5
|
1.0
|
C22
|
A:CJ2402
|
4.4
|
38.3
|
1.0
|
C19
|
A:CJ2402
|
4.5
|
35.4
|
1.0
|
CD
|
A:PRO119
|
4.6
|
29.2
|
1.0
|
CD
|
A:PRO318
|
4.6
|
46.0
|
1.0
|
O
|
A:ASN167
|
4.7
|
31.2
|
1.0
|
CA
|
A:ASN167
|
4.7
|
33.7
|
1.0
|
CA
|
A:SER118
|
4.9
|
31.5
|
1.0
|
CE2
|
A:PHE306
|
5.0
|
55.9
|
1.0
|
C20
|
A:CJ2402
|
5.0
|
35.2
|
1.0
|
|
Fluorine binding site 2 out
of 6 in 6f2u
Go back to
Fluorine Binding Sites List in 6f2u
Fluorine binding site 2 out
of 6 in the Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F402
b:40.2
occ:1.00
|
F27
|
A:CJ2402
|
0.0
|
40.2
|
1.0
|
C25
|
A:CJ2402
|
1.4
|
38.6
|
1.0
|
F26
|
A:CJ2402
|
2.2
|
42.0
|
1.0
|
F28
|
A:CJ2402
|
2.2
|
39.4
|
1.0
|
C23
|
A:CJ2402
|
2.4
|
36.7
|
1.0
|
C21
|
A:CJ2402
|
2.7
|
35.8
|
1.0
|
OD1
|
A:ASN167
|
3.3
|
32.6
|
1.0
|
CD2
|
A:PHE306
|
3.5
|
54.0
|
1.0
|
CE2
|
A:PHE306
|
3.6
|
55.9
|
1.0
|
CG
|
A:ASN167
|
3.6
|
34.0
|
1.0
|
OH
|
A:TYR216
|
3.7
|
32.0
|
1.0
|
C24
|
A:CJ2402
|
3.7
|
34.1
|
1.0
|
ND2
|
A:ASN167
|
3.9
|
31.4
|
1.0
|
O
|
A:HOH502
|
4.0
|
38.6
|
1.0
|
C19
|
A:CJ2402
|
4.1
|
35.4
|
1.0
|
CB
|
A:ASN167
|
4.3
|
31.4
|
1.0
|
CG
|
A:PHE306
|
4.5
|
55.9
|
1.0
|
CZ
|
A:PHE306
|
4.5
|
52.8
|
1.0
|
C22
|
A:CJ2402
|
4.8
|
38.3
|
1.0
|
N18
|
A:CJ2402
|
4.9
|
34.5
|
1.0
|
CE2
|
A:TYR319
|
4.9
|
49.6
|
1.0
|
C20
|
A:CJ2402
|
5.0
|
35.2
|
1.0
|
O
|
A:HOH556
|
5.0
|
36.9
|
1.0
|
CZ
|
A:TYR216
|
5.0
|
33.0
|
1.0
|
OH
|
A:TYR319
|
5.0
|
44.0
|
1.0
|
|
Fluorine binding site 3 out
of 6 in 6f2u
Go back to
Fluorine Binding Sites List in 6f2u
Fluorine binding site 3 out
of 6 in the Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F402
b:39.4
occ:1.00
|
F28
|
A:CJ2402
|
0.0
|
39.4
|
1.0
|
C25
|
A:CJ2402
|
1.4
|
38.6
|
1.0
|
F26
|
A:CJ2402
|
2.2
|
42.0
|
1.0
|
F27
|
A:CJ2402
|
2.2
|
40.2
|
1.0
|
C23
|
A:CJ2402
|
2.4
|
36.7
|
1.0
|
C24
|
A:CJ2402
|
2.9
|
34.1
|
1.0
|
CE2
|
A:PHE306
|
3.0
|
55.9
|
1.0
|
C21
|
A:CJ2402
|
3.5
|
35.8
|
1.0
|
CD2
|
A:PHE306
|
3.7
|
54.0
|
1.0
|
CZ
|
A:PHE306
|
4.0
|
52.8
|
1.0
|
C22
|
A:CJ2402
|
4.2
|
38.3
|
1.0
|
CB
|
A:SER308
|
4.4
|
62.0
|
1.0
|
CG
|
A:PRO318
|
4.6
|
44.2
|
1.0
|
C19
|
A:CJ2402
|
4.7
|
35.4
|
1.0
|
SD
|
A:MET120
|
4.7
|
47.0
|
1.0
|
CD
|
A:PRO318
|
4.9
|
46.0
|
1.0
|
CG
|
A:PHE306
|
5.0
|
55.9
|
1.0
|
C20
|
A:CJ2402
|
5.0
|
35.2
|
1.0
|
|
Fluorine binding site 4 out
of 6 in 6f2u
Go back to
Fluorine Binding Sites List in 6f2u
Fluorine binding site 4 out
of 6 in the Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F402
b:39.7
occ:1.00
|
F26
|
B:CJ2402
|
0.0
|
39.7
|
1.0
|
C25
|
B:CJ2402
|
1.4
|
35.6
|
1.0
|
F27
|
B:CJ2402
|
2.2
|
35.8
|
1.0
|
F28
|
B:CJ2402
|
2.2
|
39.0
|
1.0
|
C23
|
B:CJ2402
|
2.3
|
35.8
|
1.0
|
C24
|
B:CJ2402
|
3.0
|
36.0
|
1.0
|
CB
|
B:ASN167
|
3.3
|
29.1
|
1.0
|
CG
|
B:ASN167
|
3.3
|
27.1
|
1.0
|
C21
|
B:CJ2402
|
3.4
|
37.3
|
1.0
|
ND2
|
B:ASN167
|
3.6
|
28.8
|
1.0
|
CE
|
B:MET120
|
3.7
|
37.5
|
1.0
|
OD1
|
B:ASN167
|
3.8
|
30.1
|
1.0
|
OG
|
B:SER118
|
3.8
|
33.6
|
1.0
|
CG
|
B:PRO318
|
4.1
|
41.9
|
1.0
|
CB
|
B:SER118
|
4.2
|
31.1
|
1.0
|
C22
|
B:CJ2402
|
4.3
|
35.0
|
1.0
|
C19
|
B:CJ2402
|
4.5
|
34.9
|
1.0
|
CD
|
B:PRO119
|
4.7
|
26.0
|
1.0
|
CD
|
B:PRO318
|
4.7
|
42.7
|
1.0
|
O
|
B:ASN167
|
4.7
|
31.1
|
1.0
|
CA
|
B:ASN167
|
4.7
|
28.5
|
1.0
|
C20
|
B:CJ2402
|
4.9
|
33.8
|
1.0
|
CA
|
B:SER118
|
5.0
|
29.2
|
1.0
|
|
Fluorine binding site 5 out
of 6 in 6f2u
Go back to
Fluorine Binding Sites List in 6f2u
Fluorine binding site 5 out
of 6 in the Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F402
b:35.8
occ:1.00
|
F27
|
B:CJ2402
|
0.0
|
35.8
|
1.0
|
C25
|
B:CJ2402
|
1.4
|
35.6
|
1.0
|
F28
|
B:CJ2402
|
2.2
|
39.0
|
1.0
|
F26
|
B:CJ2402
|
2.2
|
39.7
|
1.0
|
C23
|
B:CJ2402
|
2.4
|
35.8
|
1.0
|
C21
|
B:CJ2402
|
2.7
|
37.3
|
1.0
|
OD1
|
B:ASN167
|
3.2
|
30.1
|
1.0
|
CG
|
B:ASN167
|
3.4
|
27.1
|
1.0
|
OH
|
B:TYR216
|
3.5
|
28.2
|
1.0
|
C24
|
B:CJ2402
|
3.7
|
36.0
|
1.0
|
O
|
B:HOH514
|
3.7
|
35.1
|
1.0
|
ND2
|
B:ASN167
|
3.8
|
28.8
|
1.0
|
CD1
|
B:PHE306
|
4.1
|
51.3
|
1.0
|
C19
|
B:CJ2402
|
4.1
|
34.9
|
1.0
|
CB
|
B:ASN167
|
4.1
|
29.1
|
1.0
|
CE1
|
B:PHE306
|
4.3
|
51.2
|
1.0
|
O
|
B:HOH557
|
4.7
|
37.7
|
1.0
|
OH
|
B:TYR319
|
4.7
|
36.8
|
1.0
|
C22
|
B:CJ2402
|
4.8
|
35.0
|
1.0
|
CZ
|
B:TYR216
|
4.8
|
30.3
|
1.0
|
CE2
|
B:TYR319
|
4.9
|
44.9
|
1.0
|
N18
|
B:CJ2402
|
4.9
|
30.2
|
1.0
|
C20
|
B:CJ2402
|
5.0
|
33.8
|
1.0
|
O7N
|
B:NAP401
|
5.0
|
29.8
|
1.0
|
|
Fluorine binding site 6 out
of 6 in 6f2u
Go back to
Fluorine Binding Sites List in 6f2u
Fluorine binding site 6 out
of 6 in the Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid
 Mono view
 Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F402
b:39.0
occ:1.00
|
F28
|
B:CJ2402
|
0.0
|
39.0
|
1.0
|
C25
|
B:CJ2402
|
1.4
|
35.6
|
1.0
|
F27
|
B:CJ2402
|
2.2
|
35.8
|
1.0
|
F26
|
B:CJ2402
|
2.2
|
39.7
|
1.0
|
C23
|
B:CJ2402
|
2.4
|
35.8
|
1.0
|
C24
|
B:CJ2402
|
3.0
|
36.0
|
1.0
|
CE
|
B:MET120
|
3.4
|
37.5
|
1.0
|
C21
|
B:CJ2402
|
3.5
|
37.3
|
1.0
|
CE1
|
B:PHE306
|
3.6
|
51.2
|
1.0
|
CD1
|
B:PHE306
|
3.8
|
51.3
|
1.0
|
CB
|
B:SER308
|
4.0
|
59.2
|
1.0
|
C22
|
B:CJ2402
|
4.3
|
35.0
|
1.0
|
OG
|
B:SER308
|
4.7
|
57.9
|
1.0
|
C19
|
B:CJ2402
|
4.7
|
34.9
|
1.0
|
CZ
|
B:PHE306
|
4.8
|
52.8
|
1.0
|
CG
|
B:PRO318
|
4.8
|
41.9
|
1.0
|
C20
|
B:CJ2402
|
5.0
|
33.8
|
1.0
|
|
Reference:
A.C.Pippione,
I.M.Carnovale,
D.Bonanni,
M.Sini,
P.Goyal,
E.Marini,
K.Pors,
S.Adinolfi,
D.Zonari,
C.Festuccia,
W.Y.Wahlgren,
R.Friemann,
R.Bagnati,
D.Boschi,
S.Oliaro-Bosso,
M.L.Lolli.
Potent and Selective Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors Based on the Benzoisoxazole Moiety: Application of A Bioisosteric Scaffold Hopping Approach to Flufenamic Acid. Eur J Med Chem V. 150 930 2018.
ISSN: ISSN 1768-3254
PubMed: 29602039
DOI: 10.1016/J.EJMECH.2018.03.040
Page generated: Thu Aug 1 19:51:21 2024
|